Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Socioeconomic Inequalities in Prevalence, Awareness, Treatment and Control of Hypertension: Evidence From the Persian Cohort Study Publisher Pubmed



Amini M1 ; Moradinazar M1 ; Rajati F2 ; Soofi M3 ; Sepanlou SG4 ; Poustchi H5 ; Eghtesad S5 ; Moosazadeh M6 ; Harooni J7 ; Aghazadehattari J8 ; Fallahi M9 ; Fattahi MR10 ; Ansarimoghaddam A11 ; Moradpour F12 Show All Authors
Authors
  1. Amini M1
  2. Moradinazar M1
  3. Rajati F2
  4. Soofi M3
  5. Sepanlou SG4
  6. Poustchi H5
  7. Eghtesad S5
  8. Moosazadeh M6
  9. Harooni J7
  10. Aghazadehattari J8
  11. Fallahi M9
  12. Fattahi MR10
  13. Ansarimoghaddam A11
  14. Moradpour F12
  15. Nejatizadeh A13
  16. Shahmoradi M14
  17. Mansourghanaei F15
  18. Ostadrahimi A16
  19. Ahmadi A17
  20. Khaledifar A17
  21. Saghi MH9
  22. Saki N18
  23. Mohebbi I8
  24. Homayounfar R19
  25. Farjam M19
  26. Nadimi AE20
  27. Kahnooji M20
  28. Pourfarzi F21
  29. Zamani B21
  30. Rezaianzadeh A22
  31. Johari MG23
  32. Mirzaei M24
  33. Dehghani A25
  34. Motlagh SFZ7
  35. Rahimi Z26
  36. Malekzadeh R27
  37. Najafi F28
Show Affiliations
Authors Affiliations
  1. 1. Behavioral Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Health Education and Promotion, Research Center for Environmental Determinants of Health, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
  3. 3. Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
  4. 4. Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
  7. 7. Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
  8. 8. Clinical Research Institute, Occupational Medicine Center, Social Determinants of Health Research Center, Urmia University of Medical Sciences, Urmia, Iran
  9. 9. Department of Occupational Health Engineering, School of Public Health, Non Communicable Disease Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
  10. 10. Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  11. 11. Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
  12. 12. Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran
  13. 13. Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  14. 14. Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
  15. 15. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
  16. 16. Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  17. 17. Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  18. 18. Hearing Research Center, Department of Otolaryngology, Head and Neck Surgery, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  19. 19. NonCommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  20. 20. Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  21. 21. Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
  22. 22. Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  23. 23. Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  24. 24. Yazd Cardiovascular Research Centre, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  25. 25. Centre For Healthcare Data Modeling, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  26. 26. Hearing Research Center, Department of Biostatistics and Epidemiology, School of Public Health, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  27. 27. Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  28. 28. Department of Epidemiology, School of Health, Research Center for Environmental Determinants of Health, Research Institute for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran

Source: BMC Public Health Published:2022


Abstract

Background: Elevated blood pressure is associated with cardiovascular disease, stroke and chronic kidney disease. In this study, we examined the socioeconomic inequality and its related factors in prevalence, Awareness, Treatment and Control (ATC) of hypertension (HTN) in Iran. Method: The study used data from the recruitment phase of The Prospective Epidemiological Research Studies in IrAN (PERSIAN). A sample of 162,842 adults aged > = 35 years was analyzed. HTN was defined according to the Joint National Committee)JNC-7(. socioeconomic inequality was measured using concentration index (Cn) and curve. Results: The mean age of participants was 49.38(SD = ± 9.14) years and 44.74% of the them were men. The prevalence of HTN in the total population was 22.3%(95% CI: 20.6%; 24.1%), and 18.8%(95% CI: 16.8%; 20.9%) and 25.2%(95% CI: 24.2%; 27.7%) in men and women, respectively. The percentage of awareness treatment and control among individuals with HTN were 77.5%(95% CI: 73.3%; 81.8%), 82.2%(95% CI: 70.2%; 81.6%) and 75.9%(95% CI: 70.2%; 81.6%), respectively. The Cn for prevalence of HTN was -0.084. Two factors, age (58.46%) and wealth (32.40%), contributed most to the socioeconomic inequality in the prevalence of HTN. Conclusion: The prevalence of HTN was higher among low-SES individuals, who also showed higher levels of awareness. However, treatment and control of HTN were more concentrated among those who had higher levels of SES, indicating that people at a higher risk of adverse event related to HTN (the low SES individuals) are not benefiting from the advantage of treatment and control of HTN. Such a gap between diagnosis (prevalence) and control (treatment and control) of HTN needs to be addressed by public health policymakers. © 2022, The Author(s).
Other Related Docs
24. Explaining Unequal Levels of Social Capital in Tehran, Social Indicators Research (2018)